IMKELDI is the first oral liquid form of imatinib used to treat certain forms of leukemia and other cancers. Previous Post Nifty 50 hits 3-week high led by HDFC Bank and Adani Group stocks Next Post Murugappa Group firm Tube Investments acquires 67% stake in Kcaltech System for ₹62 crore Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
